Allogene Therapeutics Inc (ALLO) EPS is poised to hit -0.29 next quarter: How Investors Can Make It Count the Most?
Allogene Therapeutics Inc (NASDAQ: ALLO) started the day on Thursday, with a price decrease of -0.64% at $1.56, before settling in for the price of